Leadership

Stephen Bloch, MD

Co-Founder and CEO

Alessandra Di Bacco

Venture Partner, Takeda Oncology

Denis Patrick

Vice President Emerging Science & Innovation, Managing Partner Pfizer Ventures, Head of Partnering Innovation

Ian Taylor, PhD

Chief Scientific Officer, Arvinas

Derek Yoon

President and CEO, Solasta Ventures

Richard Flavell, PhD

Yale – Sterling Professor, Chairman Emeritus of Immunobiology, Howard Hughes Medical Institute Investigator

Susan Kaech, PhD

Salk Institute* – Director NOMIS Center for Immunobiology and Microbial Pathogenesis, NOMIS Chair

*Participation by Dr. Kaech as a member of the Scientific Advisory Board does not constitute or imply endorsement by the Salk Institute for Biological Studies

Nils Lonberg, PhD

Executive in Residence – Canaan Partners

Former SVP Biologics Discovery, Oncology Discovery – Bristol-Myers Squibb Partnered w/ Jim Allison on CTLA-4 drug development

Mario Sznol, MD

Co-Director, Yale Cancer Immunology; Skin Cancer institute

Leader of the Melanoma/Renal Cancer Translational Team, Former president Society of Immunotherapy in Cancer (SITC)

Stephen Bloch, MD

Co-Founder and CEO

Charles Fuchs MD, MPH

Senior Vice President, Global Head Oncology and Hematology Drug Development – Genentech Roche, Former Physician-in-Chief Yale-Smilow Cancer Center

Sidi Chen, PhD

Associate Professor, Group Leader, Department of Genetics & Systems Biology Institute, Yale Cancer Systems Biology Center

Yale University